Merck wraps up $1.8bn acquisition of Pandion Therapeutics
Merck has wrapped up its previously announced $1.85 billion acquisition of Massachusetts-based clinical-stage biotech company Pandion Therapeutics. The pharma giant said that it had successfully ... Read More
Sterling Pharma acquires antibody drug conjugate manufacturer ADC Bio
Sterling Pharma Solutions has acquired ADC Biotechnology (ADC Bio), a bioconjugation development services business based in the UK, which specializes in antibody drug conjugates (ADCs). ... Read More
Siemens Mobility wins $145m contracts to modernize Sydney rail network
Siemens Mobility has secured a couple of contracts worth around AUD190 million ($145 million) for upgrading and modernizing the Sydney rail network from the New ... Read More
Bacardi launches BOMBAY SAPPHIRE & TONIC cans in US
Spirits giant Bacardi has launched BOMBAY SAPPHIRE & TONIC cans in the US, a bar quality ready-to-drink gin and tonic. BOMBAY SAPPHIRE & TONIC combines ... Read More
Royal Canin to invest $200m in pet food facility in Lebanon, Tennessee
Royal Canin, a pet health nutrition company owned by Mars, is investing more than $200 million to expand its Lebanon facility in Tennessee to support ... Read More
Fresh Express rolls out three new salad kit flavors in Canada
Fresh Express has launched three new salad kit flavors in Canada, which include the Twisted Caesar Classic Caesar, Twisted Caesar Asian Caesar Chopped Salad Kits, ... Read More
Dr. Reddy’s Laboratories launches Sapropterin dihydrochloride powder in US
Dr. Reddy's Laboratories has launched Sapropterin Dihydrochloride Powder for Oral Solution, 100mg, a generic of BioMarin’s Kuvan (sapropterin dihydrochloride) Powder for Oral Solution, 100 mg, ... Read More
Mission Barns raises $24m in Series A round for cultivated fat technology
Mission Barns, a cellular agriculture company based in Silicon Valley, has raised $24 million in a Series A round to scale up its cultivated fat ... Read More
Gan & Lee gets EMA orphan drug status for GLR2007 in glioma
Gan & Lee Pharmaceuticals has been granted orphan drug designation for GLR2007 from the European Medicine Agency (EMA) for the treatment of glioma, a type ... Read More
Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL
Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type ... Read More